Waters BD Onclarity HPV assay is intended to remove barriers that prevent individuals from receiving routine cervical cancer screening.

April 8 (Reuters) - Lab equipment maker Waters said on Wednesday the U.S. Food and Drug Administration has cleared its ...

Today, HPV testing remains one of the preferred ways to screen for cervical cancer — and now the new at‑home HPV test brings that screening right into your home, reflecting continued advancements to ...

While India has established a cervical cancer screening framework, significant implementation hurdles remain in the current ...

"Maybe a week before I was admitted to hospital, the bleeding just wouldn't stop. It was like turning a tap on, I'd lost that ...

No one looks forward to getting a pap smear. No matter how much you like your gyno, lying on your back with your feet in the stirrups while they probe your most sensitive area isn’t exactly a fun ...

Waters Corporation (WAT) stock gains as the FDA clears the company's Onclarity HPV self-collection kit for use with BD’s (BDX ...

The US FDA's approval of Waters' at-home cervical cancer screening kit marks a significant step in enhancing early detection and reducing fatalities. This move positively impacted Waters' stocks, ...

Dr. Karen Yeates outlines advances in vaccination, HPV testing, and AI-assisted screening to help tackle cervical cancer in ...

Pamela Alexander was 43 when she was diagnosed with stage 3B cervical cancer after ignoring screening reminders and symptoms ...

Mongolia is set to screen at least 20,000 women in their 30s and 40s this year for Human papillomavirus (HPV), a leading ...